Variables | Intervention ( |
Control ( |
|||
---|---|---|---|---|---|
% | % | ||||
47.06 | 8.45 | 45.31 | 9.81 | 0.587 | |
1.000 | |||||
High | 10 | 30.30 | 10 | 30.30 | |
Low | 7 | 21.20 | 6 | 18.20 | |
0.656 | |||||
Ovarian | 4 | 12.10 | 2 | 6.10 | |
Cervical | 13 | 39.40 | 14 | 42.40 | |
0.296 | |||||
Early | 8 | 24.20 | 11 | 33.30 | |
Advanced | 9 | 27.30 | 5 | 15.20 | |
1.000 | |||||
≤3 | 12 | 36.40 | 12 | 36.40 | |
>3 | 5 | 15.10 | 4 | 12.10 | |
1.000 | |||||
Platinum | 15 | 45.50 | 15 | 45.50 | |
Non-platinum | 2 | 6.00 | 1 | 3.00 | |
4.29 | 1.75 | 3.54 | 1.68 | 0.220 | |
1.37 | 0.29 | 1.42 | 0.38 | 0.622 |
Variables/groups | Time | Effect size (ES) | |||
---|---|---|---|---|---|
Day 1 (pretest) | Day 4 | Day 8 (posttest) | |||
PFS Score (mean, SD) | |||||
Intervention ( |
4.29 ± 1.75 | 5.03 ± 1.99 | 3.52 ± 1.52 | 0.012 |
0.443 |
Control ( |
3.54 ± 1.68 | 4.65 ± 2.01 | 3.57 ± 1.90 | 0.152 | - |
HADS Score (mean, SD) | |||||
Intervention ( |
1.37 ± 0.29 | 1.34 ± 0.25 | 1.28 ± 0.36 | 0.767 | - |
Control ( |
1.42 ± 0.38 | 1.42 ± 0.35 | 1.46 ± 0.35 | 0.793 | - |
Variable | Intervention ( |
Control ( |
|||
---|---|---|---|---|---|
Median (IQR1-IQR3) | Min–Max | Median (IQR1-IQR3) | Min–Max | ||
Cortisol level | |||||
Day 1 | 0.38 (0.31–0.64) | 0.25–0.88 | 0.51 (0.38–0.70) | 0.20–2.35 | 0.15 |
Day 8 | 2.97 (1.26–5.18) | 0.39–6.91 | 2.30 (0.99–9.09) | 0.43–23.38 | 0.83 |
0.0003 |
0.001 |